Asthma Control Assessment Via ACT and DRC in Asthmatics Treated With Seretide (50/250) Over 12 Weeks
Latest Information Update: 20 Sep 2023
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms VIA-CONTROL
- Sponsors GlaxoSmithKline; GSK
Most Recent Events
- 08 May 2008 New trial record.